Biondo Focus Fund Investor Class (BFONX)

16.39
Net Asset Value
-0.61%
1 Day
+1.30%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
3.59%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in a combination of long and short positions in (1) common stock of U.S. companies of any capitalization; (2) American depositary receipts ("ADRs") representing common stock of foreign companies; (3) investment-grade fixed-income securities; (4) exchange-traded funds and (5) options on common stock, ADRs and ETFs. It may also employ leverage including bank borrowing of up to 33% of the fund's assets (defined as net assets plus borrowing for investment purposes). The fund is non-diversified.

Performance

1 month+0.80% 3 years+17.90%
3 months+2.95% 5 years+9.80%
1 year+16.32% Since inception+9.64%
Data through --

Peer Comparisonvs. Large growth

 BFONXCategory
Performance 5-yr return+9.80%+13.86%
Expense ratio3.59%1.22%
Risk 5 year sharpe ratio0.500.97
Net assets$30.9M$2.8B
Average market cap$34.9B$73.6B
Average P/E26.921.3
Portfolio turnover52%52%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyBiondo Investment Advisor
Fund manager & tenureJoseph Biondo, Sr. / 5 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock106.84%
International stock0.00%
Fixed income0.00%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 32.03%
Financial service 21.84%
Hardware 16.61%
Consumer goods 15.35%
Industrial materials 7.19%
Top 10 Holdings
Portfolio weighting
PCRX Pacira Pharmaceuticals Inc13.81%
-- 10.77%
ILMN Illumina Inc9.41%
CELG Celgene9.14%
GILD Gilead Sciences7.78%
AAPL Apple7.73%
MA MasterCard6.78%
CMRX Chimerix Inc6.33%
FB Facebook5.34%
ISRG Intuitive Surgical5.26%

To view my watchlist

Not a member yet?

Sign up now for a free account